⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 29, 2023The Lancet OncologyOpen Access

Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial

Usha Menon Aleksandra Gentry‐Maharaj Matthew Burnell Andy Ryan Naveena Singh Ranjit Manchanda Jatinderpal Kalsi Robert Woolas Rupali Arora Laura Casey Anne Dawnay Aarti Sharma Karin Williamson Sophia Apostolidou Lesley Fallowfield Alistair McGuire Stuart Campbell Steven J. Skates Ian Jacobs Mahesh Parmar

View Full Paper

Ask AI

Bookmark

Share

Abstract

National Institute for Health Research, Medical Research Council, Cancer Research UK, The Eve Appeal.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Menon et al. (2023) studied this question.

synapsesocial.com/papers/69deacb24838c5c0bab0cba5 https://doi.org/10.1016/s1470-2045(23)00335-2

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialCohort Study · 2021 · 726 citations
2Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialRCT · 2015 · 1,045 citations
3Screening for Ovarian CancerRisk Assessment · 2018 · 283 citations
4Pathogenesis and heterogeneity of ovarian cancerOriginal Research · 2016 · 316 citations
5Recruitment to multicentre trials--lessons from UKCTOCS: descriptive studyRCT · 2008 · 151 citations

More related papers

Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum2015
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial2023
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage2018

More from The Lancet Oncology

Global burden of cancer attributable to infections in 2024: a worldwide incidence analysisMon,
Long-term exposure to wildfire-related PM2·5 and overall survival of older patients with lung cancer: a retrospective, registry-based cohort studyTue,